Huang et al. (2021) identified a mechanism acting through the arginine methyltransferase PRMT6 that stabilizes the interaction of RCC1 with chromatin, promoting cell proliferation and tumorigenicity. Targeting this mechanism might enhance the treatment of tumors such as glioblastoma.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.molcel.2021.02.026 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!